SCPHARMACEUTICALS INC (SCPH) Stock Earnings & Estimates
NASDAQ:SCPH - US8106481059 - Common Stock
4.76 USD
+0.19 (+4.16%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 13.593M | 36.332M 167.28% | 75.917M 108.95% | 131.97M 73.83% | 204.22M 54.75% | 262.96M 28.76% | 325.75M 23.88% | 391.87M 20.30% | 493.5M 25.93% | 549.66M 11.38% | ||
| EBITDA YoY % growth | -36.12M -40.05% | -54.77M -51.63% | -64.628M -18.00% | -48.552M 24.87% | -9.996M 79.41% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -36.16M -40.05% | -55.396M -53.20% | -64.776M -16.93% | -53.726M 17.06% | -11.934M 77.79% | 40.36M 438.19% | 86.926M 115.38% | 127.1M 46.22% | 177.66M 39.78% | 278.81M 56.93% | 331.72M 18.98% | |
| Operating Margin | N/A | -407.53% | -178.29% | -70.77% | -9.04% | 19.76% | 33.06% | 39.02% | 45.34% | 56.50% | 60.35% | |
| EPS YoY % growth | -1.30 -26.21% | -1.42 -9.23% | -1.90 -33.80% | -1.07 43.90% | -0.29 72.44% | 0.61 308.33% | 1.35 120.00% | 1.85 37.63% | 2.61 41.10% | 4.19 60.34% | 4.69 11.92% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.24 68.18% | -0.15 56.29% | -0.14 61.41% |
| Revenue Q2Q % growth | 21.018M 109.63% | 27.511M 126.43% | 26.367M 124.36% |
| EBITDA Q2Q % growth | -10.506M 41.82% | -7.65M 52.76% | -5.406M 69.45% |
| EBIT Q2Q % growth | -12.173M 32.92% | -9.323M 42.95% | -5.987M 66.28% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.34 22.73% | -0.30 | -0.04 | -11.86% |
| Q1 2025 Q2Q % growth | -0.37 -2.78% | -0.30 | -0.07 | -21.73% |
| Q4 2024 Q2Q % growth | -0.35 | -0.39 | 0.04 | 9.30% |
| Q3 2024 Q2Q % growth | -0.75 -82.93% | -0.30 | -0.45 | -147.99% |
| Q2 2024 Q2Q % growth | -0.44 -22.22% | -0.42 | -0.02 | -4.20% |
| Q1 2024 Q2Q % growth | -0.36 -20.00% | -0.45 | 0.09 | 19.24% |
| Q4 2023 Q2Q % growth | -0.35 -16.67% | -0.43 | 0.08 | 18.07% |
| Q3 2023 Q2Q % growth | -0.41 -10.81% | -0.37 | -0.04 | -10.18% |
| Q2 2023 Q2Q % growth | -0.36 -2.86% | -0.38 | 0.02 | 5.23% |
| Q1 2023 Q2Q % growth | -0.30 -7.14% | -0.37 | 0.07 | 19.42% |
| Q4 2022 Q2Q % growth | -0.30 -11.11% | -0.39 | 0.09 | 24.00% |
| Q3 2022 Q2Q % growth | -0.37 -54.17% | -0.39 | 0.02 | 5.16% |
| Q2 2022 Q2Q % growth | -0.35 -34.62% | -0.31 | -0.04 | -13.12% |
| Q1 2022 Q2Q % growth | -0.28 -7.69% | -0.32 | 0.04 | 11.45% |
| Q4 2021 Q2Q % growth | -0.27 3.57% | -0.35 | 0.08 | 22.90% |
| Q3 2021 Q2Q % growth | -0.24 27.27% | -0.32 | 0.08 | 24.91% |
| Q2 2021 Q2Q % growth | -0.26 27.78% | -0.31 | 0.05 | 15.03% |
| Q1 2021 Q2Q % growth | -0.26 25.71% | -0.31 | 0.05 | 15.03% |
| Q4 2020 Q2Q % growth | -0.28 51.72% | -0.37 | 0.09 | 24.45% |
| Q3 2020 Q2Q % growth | -0.33 | -0.39 | 0.06 | 15.42% |
| Q2 2020 Q2Q % growth | -0.36 7.69% | -0.43 | 0.07 | 16.46% |
| Q1 2020 Q2Q % growth | -0.35 25.53% | -0.55 | 0.20 | 36.16% |
| Q4 2019 Q2Q % growth | -0.58 | -0.54 | -0.04 | -8.31% |
| Q3 2019 Q2Q % growth | -0.33 | -0.46 | 0.13 | 27.70% |
| Q2 2019 Q2Q % growth | -0.39 | -0.50 | 0.11 | 21.43% |
| Q1 2019 Q2Q % growth | -0.47 | -0.53 | 0.06 | 10.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 16.041M 99.17% | 15.722M | 319K | 2.03% |
| Q1 2025 Q2Q % growth | 11.752M 92.59% | 11.861M | -109K | -0.92% |
| Q4 2024 Q2Q % growth | 12.15M 99.31% | 12.326M | -176K | -1.43% |
| Q3 2024 Q2Q % growth | 10.026M 164.12% | 11.017M | -991K | -9.00% |
| Q2 2024 Q2Q % growth | 8.054M 391.70% | 8.129M | -75K | -0.92% |
| Q1 2024 Q2Q % growth | 6.102M 195.78% | 6.097M | 5K | 0.08% |
| Q4 2023 Q2Q % growth | 6.096M | 5.636M | 460K | 8.16% |
| Q3 2023 Q2Q % growth | 3.796M | 3.459M | 337K | 9.74% |
| Q2 2023 Q2Q % growth | 1.638M | 1.65M | -12K | -0.73% |
| Q1 2023 Q2Q % growth | 2.063M | 1.394M | 669K | 47.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.2% | 0% | -2.77% |
| Revenue | 0% | -2.65% | 0% | -0.18% |